Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brenton

Showing results (111-120 of 229) with videos related to

Pageof 23
Sort By:
BMC Genomics|April 28, 2006
Differential expression of selected histone modifier genes in human solid cancersHilal Ozdağ, Andrew E Teschendorff, Ahmed Ashour Ahmed, et al.
British Journal of Cancer|January 5, 2021
Biomarkers for site-specific response to neoadjuvant chemotherapy in epithelial ovarian cancer: relating MRI changes to tumour cell load and necrosisJessica M Winfield, Jennifer C Wakefield, James D Brenton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A-ring dihalogenation increases the cellular activity of combretastatin-templated tetrazolesThomas M Beale, Daniel M Allwood, Andreas Bender, et al.
BMC Genomics|December 25, 2012
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genesIna Schulte, Elizabeth M Batty, Jessica C M Pole, et al.
Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Matrix Biology Plus|January 15, 2024
Omentum-derived matrix enables the study of metastatic ovarian cancer and stromal cell functions in a physiologically relevant environmentLisa J Neilson, Douglas Cartwright, Maija Risteli, et al.
Plos Medicine|December 21, 2016
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective StudyChristine A Parkinson, Davina Gale, Anna M Piskorz, et al.
Radiology|February 15, 2012
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effectsEvis Sala, Masako Y Kataoka, Andrew N Priest, et al.
Cancers|July 14, 2023
Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer PatientsElin Bernson, Oisín Huhn, Veronika Karlsson, et al.
Cancer Research|September 25, 2021
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian CancerLaura S M Lecker, Chiara Berlato, Eleni Maniati, et al.
Pageof 23

Showing results (111-120 of 229) with videos related to

Sort By:
Pageof 23
BMC Genomics|April 28, 2006
Differential expression of selected histone modifier genes in human solid cancersHilal Ozdağ, Andrew E Teschendorff, Ahmed Ashour Ahmed, et al.
British Journal of Cancer|January 5, 2021
Biomarkers for site-specific response to neoadjuvant chemotherapy in epithelial ovarian cancer: relating MRI changes to tumour cell load and necrosisJessica M Winfield, Jennifer C Wakefield, James D Brenton, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A-ring dihalogenation increases the cellular activity of combretastatin-templated tetrazolesThomas M Beale, Daniel M Allwood, Andreas Bender, et al.
BMC Genomics|December 25, 2012
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genesIna Schulte, Elizabeth M Batty, Jessica C M Pole, et al.
Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Matrix Biology Plus|January 15, 2024
Omentum-derived matrix enables the study of metastatic ovarian cancer and stromal cell functions in a physiologically relevant environmentLisa J Neilson, Douglas Cartwright, Maija Risteli, et al.
Plos Medicine|December 21, 2016
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective StudyChristine A Parkinson, Davina Gale, Anna M Piskorz, et al.
Radiology|February 15, 2012
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effectsEvis Sala, Masako Y Kataoka, Andrew N Priest, et al.
Cancers|July 14, 2023
Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer PatientsElin Bernson, Oisín Huhn, Veronika Karlsson, et al.
Cancer Research|September 25, 2021
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian CancerLaura S M Lecker, Chiara Berlato, Eleni Maniati, et al.
Pageof 23